Notably, we report a significant decrease in the protein levels of key components of this pathway, including β-catenin, as well as a global regulator SATB1, following statin treatment suggesting that statin indeed mediates a tumor-suppressive phenotype by targeting aberrant Wnt signaling. The gene discussed is SATB1; the disease is neoplasm.